Point72 Asset Management’s Y-mAbs Therapeutics YMAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-550
| Closed | -$4.31K | – | 1894 |
|
|
2024
Q4 | $4.31K | Sell |
550
-94,833
| -99% | -$743K | ﹤0.01% | 1231 |
|
|
2024
Q3 | $1.25M | Sell |
95,383
-263,562
| -73% | -$3.47M | ﹤0.01% | 805 |
|
|
2024
Q2 | $4.34M | Sell |
358,945
-1,168,155
| -76% | -$14.1M | 0.01% | 654 |
|
|
2024
Q1 | $24.8M | Buy |
+1,527,100
| New | +$24.8M | 0.06% | 353 |
|
|
2023
Q4 | – | Sell |
-79,600
| Closed | -$434K | – | 2187 |
|
|
2023
Q3 | $434K | Sell |
79,600
-303,987
| -79% | -$1.66M | ﹤0.01% | 1025 |
|
|
2023
Q2 | $2.6M | Buy |
383,587
+26,369
| +7% | +$179K | 0.01% | 775 |
|
|
2023
Q1 | $1.79M | Sell |
357,218
-92,212
| -21% | -$462K | 0.01% | 815 |
|
|
2022
Q4 | $2.19M | Buy |
+449,430
| New | +$2.19M | 0.01% | 750 |
|
|
2019
Q3 | – | Sell |
-30,000
| Closed | -$686K | – | 1419 |
|
|
2019
Q2 | $686K | Buy |
+30,000
| New | +$686K | ﹤0.01% | 718 |
|
|
2018
Q4 | – | Sell |
-5,000
| Closed | -$133K | – | 1101 |
|
|
2018
Q3 | $133K | Buy |
+5,000
| New | +$133K | ﹤0.01% | 806 |
|